NCT02502786 Humanized Monoclonal Antibody 3F8 (Hu3F8) With Granulocyte-Macrophage Colony Stimulating Factor (GM-CSF) in the Treatment of Recurrent Osteosarcoma Status ACTIVE_NOT_RECRUITING Phase PHASE2
NCT02501785 Caregiver Burden Within the Ambulatory Extended Recovery (AXR) Patient Population Status COMPLETED Phase N/A
NCT02498912 Cyclophosphamide Followed by Intravenous and Intraperitoneal Infusion of Autologous T Cells Genetically Engineered to Secrete IL-12 and to Target the MUC16ecto Antigen in Patients With Recurrent MUC16ecto+ Solid Tumors Status ACTIVE_NOT_RECRUITING Phase PHASE1
NCT02496585 Study to Evaluate the Efficacy and Safety of Nintedanib (BIBF 1120) + Prednisone Taper in Patients With Radiation Pneumonitis Status COMPLETED Phase PHASE2
NCT02494882 Adding Ruxolitinib to a Combination of Dasatinib Plus Dexamethasone in Remission Induction Therapy in Newly Diagnosed Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia Patients Aged 40 Years or Older Status ACTIVE_NOT_RECRUITING Phase PHASE1
NCT02494869 Dose-Response of Aerobic Training in Women at High-Risk for Development of Breast Cancer Status ACTIVE_NOT_RECRUITING Phase NA
NCT02494206 Immunotherapy for the Treatment of Breast Cancer Related Upper Extremity Lymphedema (BCRL) Status COMPLETED Phase NA
NCT02477202 Mirena® IUD's Effect on Fallopian Tube Fimbriae and Ovarian Cortical Inclusion Cyst Cell Proliferation Status COMPLETED Phase NA
NCT02465723 Detection of Acid Sphingomyelinase/Ceramide Pathway Activation in Radiotherapy Patients Using Intravoxel Incoherent Motion (IVIM) Diffusion-weighted Magnetic Resonance Imaging and Serum Biomarkers Status WITHDRAWN Phase NA
NCT02462460 Rapid Pancreatic and Ovarian Screening MR Imaging With Motion Corrected T1, T2, and Advanced Diffusion Weighted Imaging for Patients With BRCA Mutation Who Undergo Screening Breast MRI Status ACTIVE_NOT_RECRUITING Phase N/A
NCT02461550 Irreversible Electroporation Ablation for Colorectal Metastases to the Lung Status COMPLETED Phase NA
NCT02457845 HSV G207 Alone or With a Single Radiation Dose in Children With Progressive or Recurrent Supratentorial Brain Tumors Status COMPLETED Phase PHASE1
NCT02456701 Enhancing Radioiodine Incorporation Into BRAF Mutant Thyroid Cancers With the Combination of Vemurafenib and KTN3379 Status COMPLETED Phase PHASE1
NCT02455505 Identifying Family Members in Need of Support While Caregiving and After Loss Status ACTIVE_NOT_RECRUITING Phase N/A
NCT02450708 Selection of Allogeneic Hematopoietic Cell Donors Based on KIR and HLA Genotypes Status ACTIVE_NOT_RECRUITING Phase NA
NCT02450591 Local Therapies for Oligometastatic Non-Small Cell Lung Cancer Harboring Sensitizing EGFR Mutations Status COMPLETED Phase NA
NCT02437071 Assess the Efficacy of Pembrolizumab Plus Radiotherapy or Ablation in Metastatic Colorectal Cancer Patients Status COMPLETED Phase PHASE2
NCT02434809 Respiratory Motion-Corrected Cone-Beam CT and Intratreatment Gating Based on Electromagnetic Transponders to Reduce Target Position Uncertainty in Radiation Treatment of Lung Malignancies Status ACTIVE_NOT_RECRUITING Phase NA
NCT02429570 Meclofenamate in Subjects With Recurrent or Progressive Brain Metastasis From Solid Tumor Primary Status ACTIVE_NOT_RECRUITING Phase NA
NCT02429375 Mocetinostat (MGCD0103) Plus Brentuximab Vedotin (SGN-35) in Patients With Relapsed or Refractory Hodgkin Lymphoma Status COMPLETED Phase PHASE1/PHASE2